InvestorsHub Logo
Followers 4
Posts 37
Boards Moderated 0
Alias Born 08/02/2020

Re: Classic Warrior post# 28895

Sunday, 10/03/2021 9:50:52 AM

Sunday, October 03, 2021 9:50:52 AM

Post# of 36630
Classic warrior, big pharma could buy just Bucillamine IP, but commercialization payments will forever fund the research of all our other IP with no more share dilution (public/private share offerings). We can even have them pay for all future Bucillamine research and reformulation.

P.s. big pharma won't buy mushrooms just yet.

P.P.S. Future Dividend payments of a $1 per share per quarter.... ;)